Phase I/II, Evaluate the Safety and Efficacy of BLEX 404 With Docetaxel in Patients With Advanced/Metastatic Triple Negative Breast Cancer.
Clinical trial NCT02802423 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT02802423
- Sponsor
- BioLite, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2027-01-01
- Primary completion
- 2028-04-30
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.